Syncom Formulations (India) Ltd
Pharmaceuticals & Biotechnology | Small Cap
Syncom Formulations exhibits a mixed financial profile. The company demonstrates strong solvency and growth, indicating a solid financial foundation and promising expansion. Profitability is also a notable strength, driven by healthy margins and returns on capital. However, efficiency and financial metrics suggest areas needing attention. While liquidity is adequate, there's room to optimize cash management. The company's revenue, operating profit, and EPS are growing significantly. Syncom Formulations maintains a strong position with zero debt. While fixed asset and capital turnover are low, inventory management is efficient. The company shows potential for continued growth and profitability, but improvements in operational efficiency and financial management are crucial for sustained success.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsUndervalued
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio10.00
- Financial Ratio2.80
- Profitability Ratio9.80
- Efficiency Ratio5.00
- Coverage Ratio6.80
- Solvency Ratio10.00
- Liquidity Ratio7.04
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBullish
- 2 HoursNeutral
- 4 HoursBearish
- 1 DayBearish
- 1 WeekNeutral
- 1 MonthBullish
Syncom Formulations exhibits a mixed financial profile. The company demonstrates strong solvency and growth, indicating a solid financial foundation and promising expansion. Profitability is also a notable strength, driven by healthy margins and returns on capital. However, efficiency and financial metrics suggest areas needing attention. While liquidity is adequate, there's room to optimize cash management. The company's revenue, operating profit, and EPS are growing significantly. Syncom Formulations maintains a strong position with zero debt. While fixed asset and capital turnover are low, inventory management is efficient. The company shows potential for continued growth and profitability, but improvements in operational efficiency and financial management are crucial for sustained success.
Overall Valuation Score
P/E RATIO (TTM)
17.27
Industry Median
28.62
Small Cap Median
27.17
P/E RATIO
17.27
P/B RATIO
3.17
Industry Median
3.17
Small Cap Median
2.62
P/S RATIO
2.63
Industry Median
3.42
Small Cap Median
2.55
Others
PEG RATIO
0.37
EV/EBITDA RATIO
11.75
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹13.99 as on Jun 20, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company exhibits excellent growth across all measured metrics. This signals a strong upward trajectory in its business operations and financial performance. The company's revenue, operating profit, and EPS are growing significantly. Such robust growth is a positive indicator of the company's competitive positioning and ability to capitalize on market opportunities. Maintaining this growth momentum is crucial for long-term success.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 2.78 | 18.02 | 76.72 | 5.62 | |
| Operating Profit Growth Rate | 0 | 50 | 80 | 42.59 | |
| Earnings Per Share (EPS) Growth | -8.7 | 28.57 | 96.3 | 52.83 | |
| Asset Growth Rate | 22.73 | 7.14 | 1.98 | 29.3 | |
| Net Income Growth Rate | 0 | 25 | 96 | 55.1 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial ratios indicate some challenges in key financial metrics. Adjusted EPS and book value per share are low, suggesting potential concerns about profitability and equity value. The company's EPS and book value need to be improved. While the company has made capital expenditures, the overall financial health needs improvement. Improving earnings and managing capital expenditures are essential for enhancing financial stability.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 0.23 | 0.21 | 0.26 | 0.52 | 0.81 |
| Cash Earnings Per Share (Cash EPS) | 0.28 | 0.27 | 0.32 | 0.57 | 0.88 |
| Book Value Per Share | 2.58 | 2.72 | 3.06 | 3.64 | 4.41 |
| Dividend Per Share (DPS) | 0.03 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 11 | 21 | 8 | 10 | 12 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
Profitability metrics indicate a strong financial performance. High gross profit margins, ROCE, ROE, ROA, operating margins, and net margins suggest that the company is effectively managing its costs and generating substantial profits from its operations. These strong profitability metrics are a positive indicator of the company's financial health and its ability to deliver value to its shareholders. Maintaining these high levels of profitability is essential for sustained success.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 7.41 | 6.76 | 9.54 | 10.58 | 14.31 |
| Return on Capital Employed (ROCE) | 12.61 | 10 | 11 | 19 | 27 |
| Return on Equity (ROE) | 9.01 | 7.81 | 8.68 | 14.33 | 18.31 |
| Return on Assets (ROA) | 6.49 | 5.29 | 7.41 | 13.08 | 14.42 |
| Operating Margin | 9.26 | 9.01 | 11.45 | 11.66 | 15.75 |
| Net Margin | 9.26 | 9.01 | 9.54 | 10.58 | 15.54 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency ratios present a mixed view of the company's operational performance. While the inventory turnover and days sales in inventory indicate efficient inventory management, the fixed asset turnover, receivables turnover, receivable days, and capital turnover suggest potential areas for improvement. Efficient inventory management helps minimize holding costs and obsolescence, but the company needs to optimize the use of its fixed assets and capital as well as improve the collection of receivables.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 2.3 | 2.44 | 2.18 | 3.7 | 2.66 |
| Inventory Turnover Ratio | 10 | 10.1 | 11.29 | 13.32 | 8.06 |
| Receivables Turnover Ratio | 3.2 | 3.08 | 2.93 | 4.39 | 4.49 |
| Days Sales in Inventory Ratio | 36.5 | 36.14 | 32.33 | 27.4 | 45.29 |
| Receivable Days | 114 | 118.51 | 124.57 | 83.14 | 81.29 |
| Capital Turnover Ratio | 0.97 | 0.87 | 0.91 | 1.35 | 1.18 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The coverage ratios present a mixed picture of the company's ability to meet its financial obligations. While the interest coverage ratio is strong, the equity dividend coverage ratio is weak. A strong interest coverage ratio indicates that the company can easily meet its interest expenses, but the company does not have sufficient earnings to cover dividend payments to shareholders. The company should focus on improving its dividend coverage to enhance shareholder value.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 14 | 10 | 7.8 | 67 | 102 |
| Equity Dividend Coverage Ratio | 7.69 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The solvency position is strong, with no debt. This indicates long-term financial stability and a reduced risk of financial distress. The equity ratio is also high, suggesting that the company relies primarily on equity financing. A debt-free status provides the company with financial flexibility and the ability to pursue growth opportunities without the burden of debt repayments. Maintaining this strong solvency position is vital for sustained success.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0 | 0 | 0 | 0 | 0 |
| Debt to Equity Ratio | 0 | 0 | 0 | 0 | 0 |
| Equity Ratio | 1 | 1 | 1 | 1 | 1 |
| Debt To Asset Ratio | 0 | 0 | 0 | 0 | 0 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
Liquidity position indicates a mixed performance. While the quick ratio suggests a good ability to meet short-term obligations with its most liquid assets, the current ratio reflects an adequate capacity to cover current liabilities with current assets. However, the cash ratio and operating cash flow ratio suggest potential challenges in relying solely on cash and operating cash flows to meet immediate obligations. Healthcare companies often require maintaining sufficient liquidity to handle unforeseen expenses, so optimizing these ratios is vital.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 1.92 | 1.61 | 1.88 | 2.74 | 2.03 |
| Quick Ratio | 1.69 | 1.44 | 1.7 | 2.17 | 1.5 |
| Cash Ratio | 0 | 0.07 | 0.58 | 0.01 | 0.05 |
| Operating Cash Flow Ratio | 0.19 | 0.09 | -0.05 | 0.32 | 0.49 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Jagsonpal Pharmaceuticals Ltd | 8.51 | 33.01 | Overvalued | 58.00 | 6.42 | 43.00 |
| 2 | Amrutanjan Health Care Ltd | 8.25 | 77.37 | Highly Overvalued | 31.00 | 20.03 | 21.00 |
| 3 | Accent Microcell Ltd | 7.96 | 24.25 | Neutral | 57.00 | 18.28 | 44.00 |
| 4 | Windlas Biotech Ltd | 7.52 | 25.92 | Neutral | 105.00 | 32.19 | 66.00 |
| 5 | Lincoln Pharmaceuticals Ltd | 7.31 | 14.01 | Neutral | 98.00 | 43.88 | 88.00 |
| 6 | NGL Fine Chem Ltd | 6.98 | 39.22 | Overvalued | 73.00 | 67.39 | 48.00 |
| 7 | Syncom Formulations (India) Ltd | 6.92 | 17.27 | Undervalued | 77.00 | 0.81 | 76.00 |
| 8 | Kilitch Drugs (India) Ltd | 6.61 | 21.54 | Neutral | 37.00 | 9.27 | 30.00 |
| 9 | Kopran Ltd | 6.60 | 25.82 | Neutral | 62.00 | 6.30 | 26.00 |
| 10 | Hester Biosciences Ltd | 6.54 | 31.74 | Neutral | 87.00 | 61.24 | 57.00 |
| 11 | Sigachi Industries Ltd | 6.49 | 11.55 | Highly Undervalued | 54.00 | -2.08 | -83.00 |
| 12 | Sakar Healthcare Ltd | 5.81 | 58.66 | Highly Overvalued | 69.00 | 13.70 | 30.00 |
| 13 | Remus Pharmaceuticals Ltd | 5.31 | 25.48 | Neutral | 57.00 | 20.97 | 46.00 |
| 14 | Ind-Swift Laboratories Ltd | 4.95 | 39.28 | Neutral | 45.00 | 4.89 | 41.00 |
| 15 | Venus Remedies Ltd | 4.83 | 23.37 | Neutral | 147.00 | 74.30 | 103.00 |
| 16 | Wanbury Ltd | 4.65 | 28.62 | Neutral | 88.00 | 18.93 | 43.00 |
| 17 | Solara Active Pharma Sciences Ltd | 4.34 | -274.68 | Neutral | 187.00 | -1.50 | -7.00 |
Syncom Formulations' management demonstrates strengths in revenue and profit growth, as reflected in the recent TTM performance. However, increasing borrowings and inefficient working capital management present concerns. While a stable promoter holding indicates confidence, financial prudence is needed to maintain growth. The management's ability to balance these factors will be crucial for sustained success.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Sales Growth (TTM) | 77% | Strong revenue expansion |
| Profit Growth (TTM) | 100% | Strong profit growth | |
| Promoter Holding | 50.57% | Indicates confidence | |
| CONS | Borrowings (Mar 2024) | ₹ 72 Cr. | Increasing borrowings |
| Cash Conversion Cycle (Mar 2024) | 137 Days | Inefficient working capital management |
Financial Performance & Growth
Syncom Formulations has shown growth in financial performance. Compounded sales growth indicates expansion, with a increase in the TTM period. Compounded profit growth reflects profitability. Recent trends suggest management is driving revenue and profit.
| Metric | 2013-2015 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Sales Growth % | 17% | 3% | 18% | 77% |
| Profit Growth % | 19% | 0% | 25% | 96% |
Capital Efficiency & Returns
The capital efficiency of Syncom Formulations is mixed. ROCE has improved in the latest year, indicating better capital utilization. Cash Conversion Cycle is fluctuating, suggesting working capital management inefficiencies.
| Metric | 2014-2016 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| ROCE % | 15% | 10% | 11% | 19% |
| Cash Conversion Cycle | 37 Days | 126 Days | 137 Days | 83 Days |
Financial Health & Prudence
Syncom Formulations' financial health presents concerns. Borrowings have increased, raising leverage. The company has not been paying dividends recently. The increase in borrowings needs monitoring to ensure financial stability.
| Metric | 2013-2015 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Borrowings (₹ Cr) | 4 | 83 | 72 | 5 |
| Dividend Payout % | 19% | 0% | 0% | 0% |
Shareholding & Ownership Structure
The shareholding pattern shows a stable promoter holding, indicating confidence. The increasing number of shareholders suggests growing public interest.
| Metric | Mar 2017 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Promoter Holding % | 38.98% | 50.57% | 50.57% | 50.57% |
| FII Holding % | 0.00% | 0.00% | 0.08% | 0.11% |
| Number of Shareholders | 38,397 | 227,478 | 325,761 | 484,529 |
Syncom Formulations faces moderate risk. Strong growth in sales and profits reduces operational risk. Increasing borrowings and a fluctuating cash conversion cycle create financial risks. Stable promoter holding indicates confidence, while the absence of dividend payouts may deter some investors. Financial leverage and working capital management are essential to mitigate potential risks.
Accounting quality red flags
The financial statements appear consistent. Further detailed audit reports and deeper analysis is required.
Foreign exchange or interest rate exposure
Further investigation is needed to determine the extent of these exposures and their potential risks.
Regulatory compliance cost trends
Additional information would be required to assess this aspect of risk effectively.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1014.00Bullish
- SMA 2014.09Bearish
- SMA 5014.20Bearish
- EMA 1014.03Bullish
- EMA 2014.09Bullish
- EMA 5014.22Bearish
- DEMA 1013.98Bullish
- DEMA 2013.98Bullish
- DEMA 5014.04Bullish
- TEMA 1014.01Bullish
- TEMA 2013.95Bullish
- TEMA 5014.00Bullish
- MACD-0.08Bullish
- ADX19.66Weak Trend
- IndicatorValueSignal
- RSI47.57Neutral
- CCI-22.19Neutral
- ROC 90.64Bullish
- ROC 14-1.33Bearish
- ROC 25-1.88Bearish
- Stoch K37.88Neutral
- Stoch D29.50Neutral
- IndicatorValueSignal
- BB Upper14.33Neutral
- BB Middle14.09Neutral
- BB Lower13.86Neutral
- ATR0.14Low Volatility
- IndicatorValueSignal
- MFI39.61Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
- IndicatorValueSignal
- SMA 1014.06Bullish
- SMA 2014.24Bearish
- SMA 5014.32Bearish
- EMA 1014.08Bullish
- EMA 2014.16Bearish
- EMA 5014.32Bearish
- DEMA 1013.99Bullish
- DEMA 2014.03Bullish
- DEMA 5014.15Bearish
- TEMA 1013.98Bullish
- TEMA 2014.00Bullish
- TEMA 5013.97Bullish
- MACD-0.10Bearish
- ADX14.69Weak Trend
- IndicatorValueSignal
- RSI45.17Neutral
- CCI-67.69Neutral
- ROC 9-0.77Bearish
- ROC 14-1.47Bearish
- ROC 251.29Bullish
- Stoch K21.23Neutral
- Stoch D16.98Oversold
- IndicatorValueSignal
- BB Upper14.68Neutral
- BB Middle14.24Neutral
- BB Lower13.81Neutral
- ATR0.20Low Volatility
- IndicatorValueSignal
- MFI18.80Oversold
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1014.24Bearish
- SMA 2014.25Bearish
- SMA 5014.54Bearish
- EMA 1014.16Bearish
- EMA 2014.28Bearish
- EMA 5014.32Bearish
- DEMA 1014.04Bullish
- DEMA 2014.10Bearish
- DEMA 5014.55Bearish
- TEMA 1014.02Bullish
- TEMA 2014.00Bullish
- TEMA 50N/AN/A
- MACD-0.14Bearish
- ADX17.14Weak Trend
- IndicatorValueSignal
- RSI44.21Neutral
- CCI-82.91Neutral
- ROC 9-3.36Bearish
- ROC 14-0.42Bearish
- ROC 25-3.69Bearish
- Stoch K22.59Neutral
- Stoch D25.25Neutral
- IndicatorValueSignal
- BB Upper14.67Neutral
- BB Middle14.25Neutral
- BB Lower13.83Neutral
- ATR0.32Low Volatility
- IndicatorValueSignal
- MFI26.04Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
- IndicatorValueSignal
- SMA 1014.20Bearish
- SMA 2014.61Bearish
- SMA 5014.18Bearish
- SMA 10013.37Bullish
- SMA 20014.59Bearish
- EMA 1014.24Bearish
- EMA 2014.32Bearish
- EMA 5014.06Bearish
- EMA 10013.98Bullish
- EMA 20014.62Bearish
- DEMA 1014.07Bearish
- DEMA 2014.34Bearish
- DEMA 5014.47Bearish
- DEMA 10013.62Bullish
- DEMA 20013.34Bullish
- TEMA 1013.98Bullish
- TEMA 2014.08Bearish
- TEMA 5014.80Bearish
- TEMA 10014.30Bearish
- TEMA 20012.78Bullish
- MACD-0.02Bearish
- ADX11.07Weak Trend
- IndicatorValueSignal
- RSI45.46Neutral
- CCI-97.57Neutral
- ROC 14-5.28Bearish
- ROC 251.30Bullish
- Stoch K19.38Oversold
- Stoch D21.87Neutral
- IndicatorValueSignal
- BB Upper15.79Neutral
- BB Middle14.61Neutral
- BB Lower13.44Neutral
- ATR0.56Low Volatility
- IndicatorValueSignal
- MFI19.98Oversold
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 2013.34Bullish
- SMA 5015.16Bearish
- EMA 2013.90Bullish
- EMA 5014.82Bearish
- DEMA 2013.63Bullish
- DEMA 5013.44Bullish
- TEMA 2014.30Bearish
- TEMA 5012.69Bullish
- MACD-0.09Bullish
- ADX19.41Weak Trend
- IndicatorValueSignal
- RSI48.99Neutral
- CCI-33.25Neutral
- ROC 1419.02Bullish
- ROC 25-1.25Bearish
- Stoch K68.98Neutral
- Stoch D73.99Neutral
- IndicatorValueSignal
- BB Upper15.61Neutral
- BB Middle13.34Neutral
- BB Lower11.07Neutral
- ATR1.33Low Volatility
- IndicatorValueSignal
- MFI62.18Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 613.18Bullish
- SMA 1215.12Bearish
- SMA 2416.70Bearish
- EMA 613.87Bullish
- EMA 1214.84Bullish
- EMA 2418.36Bearish
- DEMA 613.30Bullish
- DEMA 1212.79Bullish
- DEMA 24N/AN/A
- TEMA 613.77Bullish
- TEMA 1213.15Bullish
- TEMA 24N/AN/A
- MACDN/AN/A
- ADX17.32Weak Trend
- IndicatorValueSignal
- RSI7.04Oversold
- CCIN/AN/A
- ROC 259.96Bullish
- ROC 50N/AN/A
- Stoch KN/AN/A
- Stoch DN/AN/A
- IndicatorValueSignal
- BB Upper22.26Neutral
- BB Middle16.51Neutral
- BB Lower10.76Neutral
- ATR7.35Low Volatility
- IndicatorValueSignal
- MFI49.82Neutral